These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32451257)

  • 1. Importance of timely management of patients in reducing fatality rate of coronavirus disease 2019.
    Peng Y; Xu B; Sun B; Han G; Zhou YH
    J Infect Public Health; 2020 Jun; 13(6):890-892. PubMed ID: 32451257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating Risk for Death from Coronavirus Disease, China, January-February 2020.
    Mizumoto K; Chowell G
    Emerg Infect Dis; 2020 Jun; 26(6):1251-1256. PubMed ID: 32168464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the instant case fatality rate of COVID-19 in China.
    Mi YN; Huang TT; Zhang JX; Qin Q; Gong YX; Liu SY; Xue HM; Ning CH; Cao L; Cao YX
    Int J Infect Dis; 2020 Aug; 97():1-6. PubMed ID: 32339723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global COVID-19 fatality analysis reveals Hubei-like countries potentially with severe outbreaks.
    Lv B; Li Z; Chen Y; Long C; Fu X
    J Infect; 2020 Jul; 81(1):e87-e88. PubMed ID: 32302605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lockdown Contained the Spread of 2019 Novel Coronavirus Disease in Huangshi City, China: Early Epidemiological Findings.
    Ji T; Chen HL; Xu J; Wu LN; Li JJ; Chen K; Qin G
    Clin Infect Dis; 2020 Sep; 71(6):1454-1460. PubMed ID: 32255183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].
    Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Feb; 41(2):145-151. PubMed ID: 32064853
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemic features of coronavirus disease 2019 in Hunan Province.
    Mao Y; Zeng H; Wang Y; Xiao J; Yang W; Zhou G; Liao W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):576-581. PubMed ID: 32879110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk assessment of exported risk of COVID-19 from Hubei Province].
    Hu JX; He GH; Liu T; Xiao JP; Rong ZH; Guo LC; Zeng WL; Zhu ZH; Gong DX; Yin LH; Wan DH; Zeng LL; Ma WJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Apr; 54(4):362-366. PubMed ID: 32083409
    [No Abstract]   [Full Text] [Related]  

  • 9. Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality.
    Wilson N; Kvalsvig A; Barnard LT; Baker MG
    Emerg Infect Dis; 2020 Jun; 26(6):1339-1441. PubMed ID: 32168463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.
    New York City Department of Health and Mental Hygiene (DOHMH) COVID-19 Response Team
    MMWR Morb Mortal Wkly Rep; 2020 May; 69(19):603-605. PubMed ID: 32407306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of the COVID-19 epidemic and correlation with population emigration from Wuhan, China.
    Chen ZL; Zhang Q; Lu Y; Guo ZM; Zhang X; Zhang WJ; Guo C; Liao CH; Li QL; Han XH; Lu JH
    Chin Med J (Engl); 2020 May; 133(9):1044-1050. PubMed ID: 32118644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial epidemic dynamics of the COVID-19 outbreak in China.
    Kang D; Choi H; Kim JH; Choi J
    Int J Infect Dis; 2020 May; 94():96-102. PubMed ID: 32251789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of Coronavirus Disease Case-Fatality Risk in Real Time.
    Ge Y; Sun S
    Emerg Infect Dis; 2020 Aug; 26(8):1922-1923. PubMed ID: 32315282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation between the spread of COVID-19 infections and weather variables in 30 Chinese provinces and the impact of Chinese government mitigation plans.
    Al-Rousan N; Al-Najjar H
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4565-4571. PubMed ID: 32373996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk estimation of the SARS-CoV-2 acute respiratory disease outbreak outside China.
    Kim S; Choi S; Ko Y; Ki M; Jung E
    Theor Biol Med Model; 2020 Jun; 17(1):9. PubMed ID: 32498721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 virus case fatality rate: How to avoid errors in calculation of data during the outbreak?
    Soliman AT; Alyafei F; Elalaily R
    Acta Biomed; 2020 May; 91(2):222-223. PubMed ID: 32420951
    [No Abstract]   [Full Text] [Related]  

  • 17. Unprecedented action has been taken to contain the epidemic of coronavirus disease 2019 in China.
    Wu T; Hu E; Zeng W; Zhang H; Xue X; Ma J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):334-337. PubMed ID: 32386027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal association between particulate matter pollution and case fatality rate of COVID-19 in Wuhan.
    Yao Y; Pan J; Liu Z; Meng X; Wang W; Kan H; Wang W
    Environ Res; 2020 Oct; 189():109941. PubMed ID: 32678728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel unorthodox strategies to reduce the case fatality rate of COVID-19 in high risk groups.
    Hlavaty T; Krajcovicova A
    Bratisl Lek Listy; 2020; 121(7):462-465. PubMed ID: 32989996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources.
    Zhang Z; Yao W; Wang Y; Long C; Fu X
    J Infect; 2020 Jul; 81(1):147-178. PubMed ID: 32209384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.